Sign In
Buy CYCC
$6.37
+0 (+0%)
At Close: Dec 10, 2025
Cyclacel Pharmaceuticals to Release Second Quarter 2022 Financial Results
09:15am, Wednesday, 03'rd Aug 2022
BERKELEY HEIGHTS, N.J., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative m
Why Crypto-Related Companies Traded Higher; Here Are 72 Biggest Movers From Yesterday
07:59am, Wednesday, 20'th Jul 2022 Benzinga
Gainers
Applied Blockchain, Inc. (NASDAQ: APLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings an
What Are Penny Stocks & 3 To Buy According To Analysts In July
04:27pm, Monday, 18'th Jul 2022 PennyStocks
Penny stocks to buy according to analysts.
The post What Are Penny Stocks & 3 To Buy According To Analysts In July appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
What Are Penny Stocks & 3 To Buy According To Analysts In July
12:27pm, Monday, 18'th Jul 2022
Penny stocks to buy according to analysts. The post What Are Penny Stocks & 3 To Buy According To Analysts In July appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving Premarket
10:22am, Wednesday, 13'th Jul 2022 Benzinga
Gainers
Minim, Inc. (NASDAQ: MINM) rose 42.8% to $0.52 in pre-market trading. Minim recently said Nicole Hayward Zheng will be transitioning from her role as President and Chief Marketing Officer to
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
08:52am, Friday, 01'st Jul 2022 Benzinga
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phas
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
04:03pm, Thursday, 30'th Jun 2022 Benzinga
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical
Cyclacel Pharmaceuticals Achieves Key Business Objectives in First Half of 2022 and Continues to Advance Clinical Pipeline
01:15pm, Thursday, 30'th Jun 2022 GlobeNewswire Inc.
- Completed Enrollment in Phase 1 Dose Escalation with Oral Fadraciclib in Solid Tumors -
Cyclacel To Test Higher Doses Of Fadraciclib In Solid Tumor Patients
01:01pm, Thursday, 30'th Jun 2022
Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) is adding two dose levels in a protocol amendment to test higher doses of oral fadraciclib before determining the recommended Phase 2 dose anticipated in
Cyclacel Pharmaceuticals Announces That Kenneth M. Ferguson, Ph.D. Was Elected to Its Board of Directors
11:04am, Wednesday, 22'nd Jun 2022 GlobeNewswire Inc.
BERKELEY HEIGHTS, N.J., June 22, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovativ
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q1 2022 Results - Earnings Call Transcript
08:45pm, Wednesday, 11'th May 2022
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Irina Koffler - LifeSci Advisors Spiro Rombotis - President, CEO & Executive
Cyclacel Pharmaceuticals to Release First Quarter 2022 Financial Results
01:15pm, Wednesday, 04'th May 2022 GlobeNewswire Inc.
BERKELEY HEIGHTS, N.J., May 04, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative
Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Cyc140 in Patients With Advanced Solid Tumors and Lymphomas
01:15pm, Tuesday, 19'th Apr 2022 GlobeNewswire Inc.
- CYC140, a Potent and Selective PLK1 Inhibitor to Be Evaluated as a Single Agent Across Multiple Solid Tumor and Lymphoma Types in Streamlined, Registration-Directed Study - - CYC140, a Potent and Se
Top Penny Stocks to Buy? 3 As Stock Futures Climb Before Market Open
01:25pm, Tuesday, 12'th Apr 2022 PennyStocks
Here's what you need to know about buying penny stocks on April 12th
The post Top Penny Stocks to Buy? 3 As Stock Futures Climb Before Market Open appeared first on Penny Stocks to Buy, Picks, News an
Cyclacel Pharmaceuticals Announces Publication Confirming Fadraciclib Suppresses MCL1 and Synergizes With Venetoclax in Chronic Lymphocytic Leukemia
11:00am, Tuesday, 12'th Apr 2022 GlobeNewswire Inc.
-New Preclinical Data Highlight Fadraciclib’s Apoptosis Enabling Mechanism in Leukemia-
